Stan Lapidus Email & Phone Number

Waltham, Massachusetts, US

Mercy is developing early-detection tests for cancer. Mercy's proprietary approach is to detect co-located surface proteins on exosomes in blood.

South San Francisco, California, US

Mirvie is a diagnostics company whose vision is to make pregnancy safe and predictable by delivering pivotal insights to moms and families. Mirvie's initial areas of focus are on early diagnosis of pre-eclampsia and predicting pre-term birth.

Boston, Massachusetts, US

Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer. Binx is developing a suite of offerings that service.

New York, NY, US

Lucid is a commercial-stage clinical testing laboratory conducting early detection of Barrett's Esophagus, a precursor to esophageal cancer, through its EsoGuard test.

Cambridge, MA, US

Droplet is pioneering the use of cell-free DNA in surgical drain fluid to better predict and manage recurrence in cancer patients

Boston, Massachusetts, US

PathAI uses machine learning and deep learning techniques to drive faster and more accurate diagnosis of disease.

Cambridge, Massachusetts, US

Sunbird is pioneering novel approaches for the early diagnosis of cancer and Alzheimer's disease.

Aurora, CO, US

Boston, Massachusetts, US

Co-Founded Pillar VC, a seed-stage firm co-founded by 22 top Boston CEOs and leaders. Founding Pillars serve as advisors, board members, mentors and customers to the firm’s portfolio companies.

Lapidx Research is my personal incubator for novel diagnostics and medical devices.

Cambridge, MA, US

Taught courses in design of clinical trials and critical reading of the scientific literature. Thesis advisor.

SynapDx was engaged in the development of novel laboratory tests for autism and other developmental disorders in children.

Cambridge, MA, US

Founding CEO of the first company to develop a system to sequence individual molecules of DNA.

Madison, Wisconsin, US

EXACT is revolutionizing early detection of colorectal cancer with its FDA-approved non-invasive test, Cologuard.

Cytyc revolutionized early detection of cervical cancer through the development of the modern Pap test. Am principal inventor of the company's ThinPrep®️ Pap test technology.Cytyc merged with Hologic to form the world's largest women's healthcare company.

Bsee, Electrical Engineering

Education record